Refractory Paroxysmal Ventricular Tachycardia
Authors: DOUGLAS P. ZIPES
Journal: Annals of Internal Medicine (1967)

Case Studies1 December 1967Refractory Paroxysmal Ventricular TachycardiaDOUGLAS P. ZIPES, M.D., EDWARD S. ORGAIN, M.D., F.A.C.P.DOUGLAS P. ZIPES, M.D., EDWARD S. ORGAIN, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-67-6-1251 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptParoxysmal ventricular tachycardia appears in a wide spectrum of pathologic situations (1), principally coronary artery disease, but it may occur in the absence of demonstrable heart disease (2). Current studies, based on continuous monitoring, reveal an incidence of 10 to 30% in acute myocardial infarction (3). Paroxysmal ventricular tachycardia has a poorer prognosis when it is associated with digitalis toxicity, acute myocardial infarction, congestive heart failure, shock, or the more severe forms of underlying heart disease (4, 5).The following case report presents an unusual instance of recurrent paroxysmal ventricular tachycardia, essentially refractory to preventive medical management, and discusses the...References1. FRIEDBERG CK: Diseases of the Heart. W. B. Saunders Co., Philadelphia and London, 1966. Google Scholar2. HAIREAGANORGAIN TEJTES: Paroxysmal ventricular tachycardia in the absence of demonstrable heart disease. Amer. J. Cardiol. 9: 209, 1962. CrossrefMedlineGoogle Scholar3. MELTZERKITCHELL LEJB: The incidence of arrhythmias associated with acute myocardial infarction. Progr. Cardiov. Dis. 9: 50, 1966. CrossrefGoogle Scholar4. HERRMANNPARKHEJTMANCIK GRHMMR: Paroxysmal ventricular tachycardia: a clinical and electrocardiographic study. Amer. Heart J. 57: 166, 1959. CrossrefMedlineGoogle Scholar5. COHNDONOSOFRIEDBERG LJECK: Ventricular tachycardia. Progr. Cardiov. Dis. 9: 29, 1966. CrossrefGoogle Scholar6. LOWN B: "Cardioversion" of arrhythmias. I. II. Mod. Cone. Cardiov. Dis. 33: 863, 869, 1964. MedlineGoogle Scholar7. KAYDENBRODIESTEELE HJBBJM: Procaine amide. A review. Circulation 15: 118, 1957. CrossrefMedlineGoogle Scholar8. PAULLEIGH OCG: Ventricular tachycardia: treatment with very large doses of procaine amide. Med. Clin. N. Amer. 50: 271, 1966. CrossrefMedlineGoogle Scholar9. DOUGLAS AH: Procainamide prophylaxis in recurrent ventricular tachycardia due to ischemic heart disease. New York J. Med. 65: 2476, 1965. MedlineGoogle Scholar10. PAINE R: Procainamide hydrochloride and lupus erythematosus. JAMA 194: 23, 1965. CrossrefMedlineGoogle Scholar11. CONNKENNEDYBLACKMON RDJWJR: The hemodynamic effects of diphenylhydantoin. Amer. Heart J. 73: 500, 1967. CrossrefMedlineGoogle Scholar12. WALLACECLINESEALYYOUNGTROYER AGREWCWGWG: Electrophysiologic effects of quinidine. Circ. Res. 19: 960, 1966. CrossrefMedlineGoogle Scholar13. DACK S: Antiarrhythmic agents in the treatment of ventricular tachycardia, in Mechanisms and Therapy of Cardiac Arrhythmias, edited by DREIFUS, L. S., LIKOFF, W., MOYER, J. H. Grune & Stratton, Inc., New York and London, 1966, p. 312. Google Scholar14. LOWNFAKHOSHOODTHORN BAMWBGW: The coronary care unit. JAMA 199: 188, 1967. CrossrefMedlineGoogle Scholar15. BEDYNEKWEINSTEINKAHMINTON JLKNREPR: Ventricular tachycardia. JAMA 198: 553, 1966. CrossrefMedlineGoogle Scholar16. AUSTENMORAN WGJM: Cardiac and peripheral vascular effects of lidocaine and procainamide. Amer. J. Cardiol. 16: 701, 1965. CrossrefMedlineGoogle Scholar17. BARNETT CF: The use of lidocaine (xylocaine)in the treatment of cardiac arrhythmias. Delaware Med. J. 38: 313, 1966. MedlineGoogle Scholar18. BRAUNWALD E (guest editor): Symposium on beta adrenergic receptor blockade. Amer. J. Cardiol. 18: 1966. Google Scholar19. REYNOLDSBAIRDCLIFFORD EWWMME: A clinical trial of antazoline in the treatment of arrhythmias. Amer. J. Cardiol. 14: 513, 1964. CrossrefMedlineGoogle Scholar20. LINENTHALZOLL AJPM: Prevention of ventricular tachycardia and fibrillation by intravenous isoproterenol and epinephrine. Circulation 27: 5, 1963. CrossrefMedlineGoogle Scholar21. HEIMANHELWIG DFJ: Suppression of ventricular arrhythmias by transvenous intracardiac pacing. JAMA 195: 1150, 1966. CrossrefGoogle Scholar22. MCCALLISTERMCGOONCONNOLLY BDDCDC: Paroxysmal ventricular tachycardia and fibrillation without complete heart block. Amer. J. Cardiol. 18: 898, 1966. CrossrefMedlineGoogle Scholar23. SOWTONLEATHAMCARSON EAP: The suppression of arrhythmias by artificial pacemaking. Lancet 2: 1098, 1964. CrossrefMedlineGoogle Scholar24. SCHOONMAKEROSTEENGREENFIELD FWRTJC: Thioridazine (Mellaril®)-induced ventricular tachycardia controlled with an artificial pacemaker. Ann. Intern. Med. 65: 1076, 1966. LinkGoogle Scholar25. COHENBUCCINOMORROWBRAUNWALD LSRAAGE: Recurrent ventricular tachycardia and fibrillation treated with a combination of beta-adrenergic blockade and electrical pacing. Ann. Intern. Med. 66: 945, 1967. LinkGoogle Scholar26. KIMBALLKILLIP JTT: A simple bedside method for transvenous intracardiac pacing. Amer. Heart J. 70: 35, 1965. CrossrefMedlineGoogle Scholar27. KASTORDESANCTISHARTHORNESCHWARTZ JARWJWGH: Transvenous atrial pacing in the treatment of refractory ventricular irritability. Ann. Intern. Med. 66: 939, 1967. LinkGoogle Scholar28. CRANEFIELD PF: Paired pulse stimulation and postextrasystolic potentiation in the heart. Progr. Cardiov. Dis. 8: 446, 1966. CrossrefMedlineGoogle Scholar29. GREENFIELDORGAIN JCES: The control of ventricular tachyarrhythmias by internal cardiac pacing (editorial). Ann. Intern. Med. 66: 1017, 1967. LinkGoogle Scholar30. ESTESIZLAR EHHL: Recurrent ventricular tachycardia. A case successfully treated by bilateral cardiac sympathectomy. Amer. J. Med. 31: 493, 1961. CrossrefMedlineGoogle Scholar31. WHITESMITHWICKSIMEONE JERHFA: The Autonomic Nervous System. The Macmillan Co., New York, 1952, p. 288. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Durham, North CarolinaFrom the Cardiovascular Disease Service, Department of Medicine, Duke University Medical Center, Durham, N. C.This study was supported in part by a grant from the Life Insurance Medical Research Fund, Rosemont, Pa., and by research grant HE-04807 and training grant HTS-5369, National Heart Institute, National Institutes of Health, Bethesda, Md.At the time of this study Dr. Zipes was a Fellow in Cardiovascular Disease at the Duke University Medical Center, supported by training grant HTS-5369, National Institutes of Health, Bethesda, Md.Requests for reprints should be addressed to Edward S. Orgain, M.D., Box 3085, Duke University Medical Center, Durham, N. C. 27706. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByBirth of Clinical Cardiac ElectrophysiologyTreatment of Ventricular Arrhythmias in Ambulatory PatientsSuppression of refractory recurrent ventricular tachycardia by transvenous rapid cardiac pacing and antiarrhythmic drugsMANAGEMENT OF CARDIAC TACHYARRHYTHMIAS WITH CARDIAC PACEMAKERSPermanent Pacing in the Absence of Heart Block 1 December 1967Volume 67, Issue 6Page: 1251-1257KeywordsAcute myocardial infarctionCardiovascular diseasesCardiovascular therapyHealth insuranceLongitudinal studiesResearch grantsShockStable coronary artery diseaseToxicityVentricular tachycardia Issue Published: 1 December 1967 PDF DownloadLoading ...